Method for building neuronal nicotinic acetylcholine subtype receptor cell model
A technology of acetylcholine receptors and cell models, applied in the biological field, can solve problems such as quantitative research on related compounds for the treatment and prevention of AD
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- Publication Date
- 2008-04-09
- Estimated Expiration
- Not applicable · inactive patent
Abstract
Description
technical field
[0001] The invention relates to a method in the field of biotechnology, in particular to a method for establishing a neuron nicotinic acetylcholine subtype receptor cell model. Background technique
[0002] Amyloid protein precursor (APP) APP gene exists mainly in three forms, namely APP695, APP751 and APP770, and APP695 is mainly present in brain tissue. Amyloid (Aβ) is formed by hydrolytic cleavage by β and γ secretases. The Aβ theory of Alzheimer's disease (AD) believes that under pathological conditions, the production of Aβ40 and 42 increases to form oligomers, and then forms plaques, which have multiple toxic effects on neurons, manifested as a series of symptoms of AD . Neuronal nicotinic acetylcholine receptors widely express multiple subtypes, and the α4β2 subtype (a pentamer assembled from 3 α subunits and 2 β subunits) is the most widely expressed in the central nervous system. The Aβ theory of AD believes that under pathological conditions, the...
Examples
Embodiment 1
[0020] The APP695 gene and pcDNA3.1(-) were digested with Xbal 1 and Hindlll enzymes, ligated with T4 DNA ligase after gel recovery, transformed into DH5α bacteria, and ampicillin resistance was screened for the recombinant pcDNA3.1(-)-APP695 , amplified and extracted plasmids, sequenced and identified. pcDNA3.1(-)-APP695 was transfected into SH-EP1-α4β2 cells with liposome method LipofectamineTM PLUS reagent, neomycin 500g / L pressurized selection 3 days after transfection, cell monoclonal formation after 14 days, limiting dilution Cells were monoclonalized.
Embodiment 2
[0022] Monoclonal cells were collected 34 days after stable transfection, and total cellular RNA was extracted by the Trizol method according to the instructions. Using total RAN as a template, APP695 primer 1 and primer 2 were used for PCR.
[0023] The specific PCR program is: denaturation at 94°C for 3 minutes to enter the cycle process, denaturation at 94°C for 1.5 minutes, annealing at 55°C for 1.5 minutes, extension at 72°C for 3 minutes, and renaturation at 72°C for 10 minutes after 31 cycles. PCR products were identified by gel electrophoresis; PCR was then performed with α4 and β2 gene primers, α4 primers were 5'-CCATCGCTCAGCTCATTGACG-3' and 5'-CTGGTCGGAGGGTGACTTGC-3', and β2 primers were 5'-TATTCCAATGCCGTGGTCTCC-3' and 5'- TGGTCATCGTCCTCGCTC-3', PCR product identified by gel electrophoresis.
Embodiment 3
[0025] For the positive clones selected by RT-PCR, lyse the cells, extract the cell protein, measure the protein concentration with a microplate reader, take 10 μg of the sample for SDS-polyacrylamide gel electrophoresis, use 12% separating gel, 5% stacking gel , Semi-dry electrotransfer on nitrocellulose membrane, transfer time 2h, mouse anti-human APP695 monoclonal antibody incubation for 3h, goat anti-mouse secondary antibody incubation for 1h, ECL fluorescence detection, developing and fixing, and taking pictures to detect cell clone APP695
[0026] Cells were lysed with a lysate containing protease inhibitors PMSF and AEBSF, and the protein concentration was determined by BCA method. 30.5 μg of the sample was loaded for Tris-tricine electrophoresis, using 16.5% separating gel, 10% interlayer gel, 4% stacking gel, PVDF membrane wet Transfer, membrane transfer time 1h, 6E10 monoclonal antibody incubated at room temperature for 3h, goat anti-mouse secondary antibody incubated...